Company Filing History:
Years Active: 1998
Title: Innovations by Stephen M Manzella
Introduction
Stephen M Manzella is an accomplished inventor based in Birmingham, AL (US). He has made significant contributions to the field of medical science, particularly in the treatment of diabetes mellitus and glycogen storage disease. His innovative approach has the potential to improve the lives of many individuals affected by these conditions.
Latest Patents
Stephen M Manzella holds a patent for "Methods of treating diabetes mellitus and glycogen storage disease." This invention provides a method and compounds for priming the incorporation of cellular glucose into an oligosaccharide in a cell. The method involves administering a priming amount of a membrane-permeating nontoxic glycoside, which has a suitable hydrophobic organic group linked to a hydrophilic saccharide. The hydrophilic saccharide features a nonreducing terminal sugar residue, selected from glucose or xylose. This process primes the incorporation of cellular glucose onto the glycoside to form an oligosaccharide. The patent also discloses methods wherein the administration of the glycoside is sufficient to treat diabetes mellitus and glycogen storage disease. Stephen M Manzella has 1 patent to his name.
Career Highlights
Stephen M Manzella is associated with the UAB Research Foundation, where he continues to explore innovative solutions in medical research. His work is characterized by a commitment to advancing healthcare through scientific discovery and innovation.
Collaborations
Stephen collaborates with Elias Meezan, contributing to the development of groundbreaking methods in the treatment of metabolic diseases.
Conclusion
Stephen M Manzella's contributions to the field of medical science through his innovative patent demonstrate his dedication to improving health outcomes. His work has the potential to make a significant impact on the treatment of diabetes and glycogen storage disease.